TAKEDA'S TETRAVALENT DENGUE VACCINE (TDV) CANDIDATE PROGRESSES TO PHASE III: SAFETY AND IMMUNOGENICITY OF TDV

被引：0
|
作者：
Wallace, Derek [1 ]
Tricou, Vianney [1 ]
Stinchcomb, Dan [2 ]
Amfo, Kwasi [1 ]
Borkowski, Astrid [3 ]
机构：
[1] Takeda Vaccines Pte Ltd, Singapore, Singapore
[2] Takeda Vaccines Inc, Deerfield, IL USA
[3] Takeda Pharmaceut Int AG, Zurich, Switzerland
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 95卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
61
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [1] Takeda's candidate Tetravalent Dengue Vaccine (TDV) - Progress to Phase 3
    Goh, Choo-Beng
    Brett, Jeremy
    Wallace, Derek
    Borkowski, Astrid
    Dean, Hansi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S36 - S36
  • [2] Immunogenicity and safety of Takeda's tetravalent dengue vaccine (TDV) in healthy children in Asia and Latin America
    Vashishtha, Vipin M.
    INDIAN PEDIATRICS, 2018, 55 (05) : 444 - 444
  • [3] DISSECTING THE SPECIFICITY OF THE NEUTRALIZING ANTIBODY RESPONSE TO A LIVE ATTENUATED TETRAVALENT DENGUE VACCINE (TDV) CANDIDATE
    Henein, Sandra
    Swanstrom, Jesica
    Widman, Douglas G.
    Stinchcomb, Dan T.
    Dean, Hansi
    Osorio, Jorge E.
    Partidos, Charalambos D.
    Baric, Ralph S.
    de Silva, Aravinda
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 165 - 165
  • [4] PROGRESS IN DEVELOPMENT OF TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE
    Tricou, Vianney
    Saez-Llorens, Xavier
    Yu, Delia
    Rivera, Luis
    Borkowski, Astrid
    Wallace, Derek
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 194 - 194
  • [5] INTEGRATED IMMUNOGENICITY ANALYSIS OF A TETRAVALENT DENGUE VACCINE (CYD-TDV) UP TO 4 YEARS AFTER VACCINATION
    Vigne, Claire
    Dupuy, Martin
    Richetin-Guilluy, Aline
    Guy, Bruno
    Jackson, Nicholas
    Bonaparte, Matthew
    Hu, Branda
    Saville, Melanie
    Chansinghakul, Danaya
    Noriega, Fernando
    Plennevaux, Eric
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 434 - 434
  • [6] Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
    Rupp, Richard
    Luckasen, Gary Joseph
    Kirstein, Judith Lee
    Osorio, Jorge E.
    Santangelo, Joseph D.
    Raanan, Marsha
    Smith, Mary Kathryn
    Wallace, Derek
    Gordon, Gilad S.
    Stinchcomb, Dan T.
    VACCINE, 2015, 33 (46) : 6351 - 6359
  • [7] Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV
    Wilder-Smith, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (07) : 680 - 681
  • [8] CELL-MEDIATED IMMUNITY GENERATED BY TAKEDA'S LIVE-ATTENUATED DENGUE VACCINE (TDV)
    Currier, Jeffrey
    Friberg, Heather
    Tricou, Vianney
    Egan, Michael
    Victor, Kaitlin
    Hatch, Kristin
    Low, Jenny
    Oh, Helen
    Jarman, Richard
    Wallace, Derek
    Dean, Hansi
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 241 - 241
  • [9] IMMUNOGENICITY OF THE CYD TETRAVALENT DENGUE VACCINE (CYD-TDV) USING A COMPRESSED SCHEDULE: RANDOMIZED PHASE II STUDY IN US ADULTS
    Kirstein, Judith
    Douglas, William
    Thakur, Manoj
    Boaz, Mark
    Papa, Thomas
    Skipetrova, Anna
    Plennevaux, Eric
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 433 - 433
  • [10] Clinical efficacy, Safety, and immunogenicity of a Live Attenuated Tetravalent Dengue vaccine (CYD-TDv) in Children: A Systematic Review with Meta-analysis
    Malisheni, Moffat
    Khaiboullina, Svetlana F.
    Rizvanov, Albert A.
    Takah, Noah
    Murewanhema, Grant
    Bates, Matthew
    FRONTIERS IN IMMUNOLOGY, 2017, 8
12345